CKPT Checkpoint Therapeutics, Inc: Bozor kapitallashuvining balans qiymatiga nisbati

Checkpoint Therapeutics, Inc (CKPT) - korporativ logo

Checkpoint Therapeutics teri saratoni terapiyasi uchun hamyonbop muqobil sifatida cosibelimabni ishga tushirishga tayyorgarlik ko'rmoqda. Kompaniya checkpoint inhibitorlari bozorining o'sishidan foydalanmoqda, garchi moliyalashtirish yetishmovchiligi va sinovlarning muvaffaqiyatsiz tugash xavfi jiddiy tahdidlar tug'dirsa-da. GURU.Markets platformasidagi narxning buki ko'rsatkichi aktivlarning baholanish tendentsiyasini aks ettiradi, bunda joriy ko'rsatkich 22.30 darajasida turibdi.

Checkpoint Therapeutics (CKPT) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 07.06.2025gacha

CKPT (Checkpoint Therapeutics Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Checkpoint Therapeutics|CKPT - Tahlilchilarning prognoz narxlari
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Checkpoint Therapeutics, Inc|CKPT - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Checkpoint Therapeutics|CKPT - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati checkpointtx.com|CKPT - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Checkpoint Therapeutics|CKPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Checkpoint Therapeutics, Inc|CKPT - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Checkpoint Therapeutics, Inc
Fundamental baholash:CKPT (Checkpoint Therapeutics)
Checkpoint Therapeutics Inc. tayyor mahsulotlari

Checkpoint Therapeutics (CKPT) uchun ushbu ko'rsatkich bozor baholovini sof aktivlarning haqiqiy qiymati bilan solishtiradi. Ushbu metrika bozor kapitalizatsiyasi va balans qiymati o'rtasidagi nisbatni hisoblab, aktivlarga nisbatan premium yoki diskont darajasini aniqlaydi. Tarixiy narxning balans qiymatiga nisbati (P/B) narxning aktivlar sifatiga bog'liqligini vizuallashtiradi. Iqtisodiy himoyasi zaif bo'lgan va FDA tartibga soluvchi xatarlari mavjud bo'lgan biotexnologiya kompaniyasi uchun bunday premium kritik ahamiyatga ega. Bu yerda yuqori ko'rsatkich investorlarning haddan tashqari optimizmini anglatadi.

Asosiy raqobatchilar

ONC - Kapitallashuvning sof aktivlarga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA|Bozor kapitallashuvining balans qiymatiga nisbati CVM (CEL-SCI Corporation)|Kapitallashuvning sof aktivlarga nisbati ostherapies.com (OSTX)|Bozor kapitallashuvining balans qiymatiga nisbati Radiopharm Theranostics|Balans qiymatiga nisbatan bozor qiymati Artiva Biotherapeutics Inc. ARTV|ANL (Adlai Nortye Limited) - Bozor kapitallashuvining balans qiymatiga nisbati|VERU - Bozor qiymatining balans qiymatiga koeffitsiyenti|TPST (Tempest Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|XLO (Xilio Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|RENB (Renovaro Biosciences) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati MURA|KAPA - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi OKUR (onkuretherapeutics.com)|GDTC: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Curis Inc. CRIS|Bozor kapitallashuvining balans qiymatiga nisbati APLM (Apollomics Corp)|THAR: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati advanbiomed.com|Kapitallashuvning balans qiymatiga nisbati Genprex Inc|Calidi Biotherapeutics Inc. (CLDI) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori sunshinebiopharma.com (SBFM)|Xenetic Biosciences (XBIO) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Salarius Pharmaceuticals Inc SLRX|Kapitallashuvning sof aktivlarga nisbati Purple Biotech Corp (PPBT)|Bozor kapitallashuvining balans qiymatiga multiplikatori American Oncology Network Inc AONC|Bozor kapitallashuvining balans qiymatiga nisbati BeiGene, Ltd. (BGNE)|ELEV - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ICAD|IKNA (Ikena Oncology) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NTBL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Viracta|Bozor kapitallashuvining balans qiymatiga nisbati MOR|Bozor kapitallashuvining balans qiymatiga nisbati NAYA (nayabiosciences.com)|Ascentage Pharma (AAPGV) - Bozor qiymatining balans qiymatiga nisbati